Interactions between the apolipoprotein E4 gene and modifiable risk factors for cognitive impairment: a nationally...

Area of Science:

• Neuroscience
• Genetics
• Public Health

Background:

• Few studies have rigorously examined interactions between genetic and modifiable risk factors for cognitive decline.
• The increasing prevalence of cognitive impairment (CI) and dementia necessitates understanding these complex interactions.

Purpose of the Study:

• To assess if Apolipoprotein E ε4 (APOE4) genotype status modifies the association between incident CI and key modifiable risk factors.
• To investigate the combined impact of genetic predisposition and lifestyle factors on cognitive health.

Main Methods:

• Inclusion of older adults (70+) in the US.
• Genotyping for APOE4 status and assessment of cognitive status by a clinical consensus panel.
• Utilizing Cox proportional hazard models to evaluate interactions between APOE4 status and modifiable risk factors for CI.

Main Results:

• APOE4 independently increased the hazard of CI (HRs 1.81-2.66, p<0.05), except for educational attainment.
• Joint effects of APOE4 with hypertension, depressive symptoms, hearing loss, vision impairment, smoking, and obesity significantly elevated the hazard of incident CI (p<0.01).
• The combination of APOE4 and type 2 diabetes did not show a significant association with incident CI.

Conclusions:

• The combination of APOE4 and specific modifiable risk factors presents a stronger association with incident CI than either factor in isolation.
• Understanding these gene-environment interactions is crucial for developing targeted prevention strategies for cognitive decline.